Work

Intravenous (IF) Aflibercept versus placebo in combination with irinotecan/5-FU (FOLFIRI) for second-line treatment of metastatic colorectal cancer (MCC): Results of a multinational phase III trial (EFC10262-VELOUR)

Year: 2011

Type: article

Source: Annals of Oncology

Authors: Eric Van Cutsem, Josep Tabernero, Radek Lakomý

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W255679108

FWCI: 7.374

Cites:

Cited by: 48

Related to: 10